Another, A Few Good Device for End Stage Heart Failure.
作者信息
Lee Jooyeon, Oh Jaewon, Kang Seok-Min
机构信息
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
出版信息
Int J Heart Fail. 2024 Apr 23;6(2):82-83. doi: 10.36628/ijhf.2024.0023. eCollection 2024 Apr.
Abstract
摘要
相似文献
1
Another, A Few Good Device for End Stage Heart Failure.
Int J Heart Fail. 2024 Apr 23;6(2):82-83. doi: 10.36628/ijhf.2024.0023. eCollection 2024 Apr.
2
[Perioperative coagulation management during left ventricular assist device implantation surgery for end-stage heart failure: four cases and literature review].
Zhonghua Xue Ye Xue Za Zhi. 2024 Dec 30;45(S1):47-52. doi: 10.3760/cma.j.cn121090-20241128-00488.
3
4
Long-term use of a left ventricular assist device for end-stage heart failure.
N Engl J Med. 2001 Nov 15;345(20):1435-43. doi: 10.1056/NEJMoa012175.
5
Ventricular assist device for end-stage adult congenital heart disease patients: Current status.
J Cardiol. 2023 Apr;81(4):378-384. doi: 10.1016/j.jjcc.2022.09.007. Epub 2022 Sep 21.
6
Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist device: medium-term results.
Surg Obes Relat Dis. 2015 Jan-Feb;11(1):88-93. doi: 10.1016/j.soard.2014.04.003. Epub 2014 Apr 15.
7
Ventricular assist device: saving the failing heart.
Prog Transplant. 2010 Jun;20(2):134-41. doi: 10.1177/152692481002000207.
8
[Long-term outcome of EVAHEART I implantable ventricular assist device for the treatment of end stage heart failure: clinical 3-year follow-up results of 15 cases].
Zhonghua Xin Xue Guan Bing Za Zhi. 2023 Apr 24;51(4):393-399. doi: 10.3760/cma.j.cn112148-20220614-00472.
9
Emergence of Laplace therapeutics: declaring an end to end-stage heart failure.
Congest Heart Fail. 2002 Jul-Aug;8(4):228-31, 234. doi: 10.1111/j.1527-5299.2002.01417.x.
10
Clinical experience with HeartWare left ventricular assist device in patients with end-stage heart failure.
Ann Thorac Surg. 2012 Mar;93(3):810-5. doi: 10.1016/j.athoracsur.2011.11.076. Epub 2012 Jan 29.
本文引用的文献
1
Adverse Events in Total Artificial Heart for End-Stage Heart Failure: Insight From the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE).
Int J Heart Fail. 2023 Sep 18;6(2):76-81. doi: 10.36628/ijhf.2023.0020. eCollection 2024 Apr.
2
Pig-to-human heart xenotransplantation in two recently deceased human recipients.
Nat Med. 2023 Aug;29(8):1989-1997. doi: 10.1038/s41591-023-02471-9. Epub 2023 Jul 24.
3
Biventricular assist devices and total artificial heart: Strategies and outcomes.
Front Cardiovasc Med. 2023 Jan 6;9:972132. doi: 10.3389/fcvm.2022.972132. eCollection 2022.
4
Heart transplantation after total artificial heart bridging-Outcomes over 15 years.
Clin Transplant. 2022 Nov;36(11):e14781. doi: 10.1111/ctr.14781. Epub 2022 Sep 5.
5
The ongoing quest for the first total artificial heart as destination therapy.
Nat Rev Cardiol. 2022 Dec;19(12):813-828. doi: 10.1038/s41569-022-00723-8. Epub 2022 Jun 6.
Zotero 插件